Mynosys Cellular Devices is introducing its new name as Centricity Vision, Inc., along with a new leadership team. “Centricity Vision” reflects the ophthalmic company’s core competence, as embodied by its ZEPTO Precision Cataract Surgery Platform, in creating precise, consistent, visual axis-centered capsulotomies.
The new name additionally conveys the company’s evolution, as it looks forward to expanding its vision care product pipeline beyond ZEPTO, while remaining committed to improving cataract surgery outcomes for surgeons and their patients.
The company’s ZEPTO Platform enables precise, reproducible, circular, capsulotomies that facilitate 360-degree overlap of the IOL optic. The platform integrates into the routine steps of cataract surgery without increasing operative time or space requirements. It consists of a disposable hand piece and a small, inexpensive control console. The ZEPTO precision pulse capsulotomy technology utilizes a proprietary energy control algorithm to deliver a four-millisecond energy pulse, in combination with calibrated suction, to produce accurate and strong-edged capsulotomies.
Published studies have demonstrated the ZEPTO capsulotomy edge as 2-4 times stronger than manual CCC and femtosecond laser capsulotomy. ZEPTO not only automates the anterior capsulotomy, but it also enables precise visual axis centration.
“We have evolved significantly as a company, and we think it’s time our name did, too,” said Rob Thornhill, President and CEO of Centricity Vision. “Building on our commitment to assisting surgeons in delivering the best care to their patients, our vision for the future includes leveraging our ZEPTO technology to create a suite of next-generation ophthalmic capsular management products. I’m grateful for the opportunity to work with our new management team to deliver high-quality systems to our customers and their patients.”
In addition to Rob Thornhill’s recent appointment as CEO, new appointments have been made for the following leadership roles: CFO, VP of Marketing, VP of Sales, VP of Research, Development and Manufacturing, and VP of Regulatory Affairs and Quality Assurance.
Full press release: https://www.zeptozone.com/company/news-and-events/
Source: Centricity Vision